Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityCISN / Cision Ltd. (G1992S109)
President and CEOAkeroyd Kevin D
Institutional Owners76
Institutional Shares50,142,436 - 40.32%
Common Shares Outstanding124,370,566 shares (as of 2018-03-31)
Institutional Value$ 484,882,000 USD

Institutional Stock Ownership and Shareholders()

Cision Ltd. (NYSE:CISN) has 76 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 50,142,436 shares. Largest shareholders include Bamco Inc /ny/, Price T Rowe Associates Inc /md/, JP Morgan Chase & Co, TimesSquare Capital Management, LLC, Vanguard Group Inc, Henderson Group Plc, Highbridge Capital Management Llc, 683 Capital Management, LLC, Rotation Capital Management, LP, and Pennant Capital Management, LLC.
Cision Ltd. (NYSE:CISN) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC 600,000 2,301,000 283.50 1,548 5,154 232.95
2018-05-11 13F-HR TD ASSET MANAGEMENT INC 1,240,937 893,637 -27.99 3,375 2,091 -38.04
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 278 4
2018-05-15 13F-HR Bluefin Trading, LLC 0 165,765 0 388
2018-05-15 13F-HR PIONEER INVESTMENT MANAGEMENT INC 448,300 630,600 40.66 5,321 7,296 37.12
2018-05-02 13F-HR Trellus Management Company, LLC 52,320 79,590 52.12 621 921 48.31
2018-05-15 13F-HR BlueCrest Capital Management Ltd 84,562 978
2018-05-15 13F-HR TimesSquare Capital Management, LLC 2,271,340 3,553,995 56.47 26,961 41,120 52.52
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 0 140 0 1,620
2018-05-09 13F-HR NORTHERN TRUST CORP 89,990 94,707 5.24 1,068 1,096 2.62
2018-04-18 13F-HR REINHART PARTNERS, INC. 322,730 3,734
2018-05-15 13F-HR Altshuler Shaham Ltd 54,017 625
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 268,703 3,109
2018-05-15 13F-HR STATE STREET CORP 78,250 81,055 3.58 929 938 0.97
2018-04-16 13F-HR Malaga Cove Capital, LLC 29,086 42,897 47.48 345 496 43.77
2018-05-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC 23,981 277
2018-05-14 13F-HR SPITFIRE CAPITAL LLC 606,900 7,022
2018-05-15 13F-HR Bank of New York Mellon Corp 43,881 48,835 11.29 521 565 8.45
2018-06-20 13F-HR/A City Financial Investment Co Ltd 138,579 324
2018-05-15 13F-HR CREDIT SUISSE AG/ 31,031 30,426 -1.95 368 352 -4.35
2018-05-11 13F-HR JBF Capital, Inc. Call 46,850 46,850 0.00 127 110 -13.39
2018-05-14 13F-HR AlphaOne Investment Services, LLC 2,100 24
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 0 742 0 9
2018-05-15 13F-HR Polygon Management Ltd. 50,973 309,699 507.57 139 725 421.58
2018-05-15 13F-HR ELLINGTON MANAGEMENT GROUP LLC 38,500 445
2018-05-11 13F-HR CITIGROUP INC 99 0 -100.00 1 0 -100.00
2018-05-14 13F-HR Laurion Capital Management LP 242,442 2,805
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 600,000 825,000 37.50 1,632 1,930 18.26
2018-04-13 13F-HR Steinberg Global Asset Management 177,824 185,593 4.37 2,111 2,147 1.71
2018-05-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0 542,086 0 6,272
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 31,489 0 -100.00 374 0 -100.00
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 740,800 6,385,274 761.94 2,015 73,878 3,566.40
2018-05-09 13F-HR BAMCO INC /NY/ 6,798,252 7,046,447 3.65 80,695 81,527 1.03
2018-05-15 13F-HR Davidson Kempner Capital Management LP 215,323 0 -100.00 586 0 -100.00
2018-05-15 13F-HR WOLVERINE ASSET MANAGEMENT LLC 186,036 212,535 14.24 492 489 -0.61
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 121,268 609,366 402.50 1,439 7,050 389.92
2018-05-02 13F-HR THOMPSON DAVIS & CO., INC. 500 250 -50.00 6 3 -50.00
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 19,995 263,113 1,215.89 237 3,044 1,184.39
2018-05-15 13F-HR VANGUARD GROUP INC 2,691,466 3,136,114 16.52 31,948 36,284 13.57
2018-05-12 13F-HR First Pacific Advisors, LLC 605,827 7,009
2018-05-15 13F-HR Adi Capital Management LLC 281,603 0 -100.00 3,343 0 -100.00
2018-05-15 13F-HR OXFORD ASSET MANAGEMENT 356,370 4,123
2018-05-15 13F-HR PUTNAM INVESTMENTS LLC 124,999 124,999 0.00 340 292 -14.12
2017-08-14 13F-HR/A Rotation Capital Management, LP 1,429,362 1,429,362 0.00 3,143 3,143 0.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 80,178 413,264 415.43 951 4,781 402.73
2018-04-19 13F-HR Skylands Capital, LLC 50,861 0 -100.00 604 0 -100.00
2018-05-15 13F-HR Ionic Capital Management LLC 33,628 116,078 245.18 91 272 198.90
2018-05-15 13F-HR Marshall Wace North America L.P. 615,988 7,127
2018-05-11 13F-HR CITADEL ADVISORS LLC 595,546 6,890
2018-05-15 13F-HR Moore Capital Management, LP 200,000 200,000 0.00 544 468 -13.97
2018-05-10 13F-HR JP Morgan Chase & Co 4,775,780 5,925,492 24.07 56,688 68,558 20.94
2018-05-14 13F-HR MORGAN STANLEY 2 136 6,700.00 0 2
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 0 595,546 0 6,890
2018-05-10 13F-HR Monashee Investment Management LLC 400,000 263,123 -34.22 936 3,044 225.21
2018-07-17 13F-HR EQUITEC SPECIALISTS, LLC 146,723 0 -100.00 343 0 -100.00
2018-05-15 13F-HR HighTower Advisors, LLC 61,642 719
2017-08-14 13F-HR RAIFF PARTNERS INC 10,000 103
2018-05-15 13F-HR Lion Point Capital, LP Call 64,389,500 643,895 -99.00 1,751 1,506 -13.99
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 121,120 127,028 4.88 1,438 1,470 2.23
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 6,385,274 740,800 -88.40 73,878 1,733 -97.65
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 17,606 23,189 31.71 209 268 28.23
2018-05-15 13F-HR ARROWGRASS CAPITAL PARTNERS (US) LP 503,550 0 -100.00 1,370 0 -100.00
2018-05-04 13F-HR Swiss National Bank 61,700 61,700 0.00 732 714 -2.46
2018-05-11 13F-HR Myriad Asset Management Ltd. 331,550 581,550 75.40 902 1,361 50.89
2018-05-14 13F-HR KOCH INDUSTRIES INC 10,347 120
2018-05-03 13F-HR BRONFMAN E.L. ROTHSCHILD, L.P. 1,000 12
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 29 29 0.00 0 0
2018-05-10 13F-HR Monashee Investment Management LLC 400,000 936
2018-07-17 13F-HR FOX RUN MANAGEMENT, L.L.C. 23,148 0 -100.00 268 0 -100.00
2018-05-08 13F-HR STEVENS CAPITAL MANAGEMENT LP 15,313 0 -100.00 182 0 -100.00
2018-05-14 13F-HR ZAZOVE ASSOCIATES LLC 22,200 249,136 1,022.23 60 583 871.67
2018-05-15 13F-HR Linden Advisors LP 172,107 227,343 32.09 454 525 15.64
2018-05-15 13F-HR UBS Group AG 0 1,523 0 4
2018-05-15 13F-HR Advisor Group, Inc. 100 100 0.00 1 1 0.00
2018-05-14 13F-HR Renaissance Technologies LLC 153,200 703,500 359.20 1,818 8,139 347.69
2018-05-07 13F-HR Engineers Gate Manager LP 16,183 0 -100.00 192 0 -100.00
2018-05-15 13F-HR D. E. Shaw & Co., Inc. 18,215 211
2018-04-30 13F-HR GILDER GAGNON HOWE & CO LLC 154,225 127,290 -17.46 1,831 1,473 -19.55
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 34,103 395
2018-05-15 13F-HR BARCLAYS PLC 0 6,668 0 77
2018-05-14 13F-HR HENDERSON GROUP PLC 2,696,723 2,681,681 -0.56 32,010 31,027 -3.07
2018-05-15 13F-HR 683 Capital Management, LLC 1,100,000 1,530,000 39.09 2,992 3,580 19.65
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 250 160,990 64,296.00 1 1,863 186,200.00
2018-05-09 13F-HR BlackRock Inc. 202,689 602,106 197.06 2,405 6,966 189.65
2018-07-18 13F-HR Castle Creek Arbitrage, LLC 295,860 0 -100.00 663 0 -100.00
2018-05-08 13F-HR TEACHER RETIREMENT SYSTEM OF TEXAS 12,446 0 -100.00 148 0 -100.00
2018-05-03 13F-HR Trexquant Investment LP 40,786 472
2018-05-15 13F-HR Pennant Capital Management, LLC 1,818,574 1,200,000 -34.01 21,586 13,884 -35.68
2018-05-15 13F-HR Alyeska Investment Group, L.P. Call 300,000 0 -100.00 3,561 0 -100.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ Call 460,395 524,633 13.95 1,252 1,227 -2.00
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 160,990 250 -99.84 1,863 1 -99.95
2018-05-15 13F-HR Schonfeld Strategic Advisors LLC 14,683 19,157 30.47 174 222 27.59
2018-05-14 13F-HR Ashler Capital Llc 14,159 164
2018-05-15 13F-HR JANE STREET GROUP, LLC 44,755 518

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Top Analyst Upgrades and Downgrades: Accenture, Ally, Diageo, Harley-Davidson, KB Home, NetApp, Nike, Sirius XM, Walgreens and More

2018-06-29 247wallst
Stocks were looking for a stronger open on Friday for the last trading day of the second quarter of 2018. That said, the year-to-date performance has been down 2% for the Dow Jones industrial average and a 1.5% gain for the S&P 500. The trend of buying the dips has not worked as well as it has in prior years, and many investors have been considering how they want their investments positioned for the longer term. (121-0)

Cision's (CISN) CEO Kevin Akeroyd on Q1 2018 Results - Earnings Call Transcript

2018-05-12 seekingalpha
Good afternoon, and welcome to Cision Ltd's First Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that this event is being recorded.

Cision: Warrant Exchange Offer Is Extremely Positive Catalyst For The Stock

2018-04-25 seekingalpha
On April 17, CISN announced an exchange offer for its warrants (CISNWS) to receive 0.26 shares of CISN stock for each outstanding warrant. The market reacted positively to the announcement with CISN shares climbing 20% since the secondary announcement in late March. At CISN’s current share price of $13.80 per share, the implied value of the warrant offer is $3.60 per warrant.

CUSIP: G1992S109